307. Diabetes Medication Management - What's New & Expanding the RDN's Role

FNCE Recorded Sessions from 2016

Today, health care providers have a wide array of glucose-lowering medications from which to choose based on the individual's physiological defects.

  • SKU FNCE16307
Member Price
$32.00
Nonmember Price
$37.00

This product is free for those who attended FNCE® 2016.

Due to the progressive nature of type 2 diabetes, nutrition and physical activity interventions alone are generally not effective in maintaining glycemic control long-term. For many, glucose lowering medications will be needed. Today, health care providers have a wide array of glucose-lowering medications from which to choose based on the individual's physiological defects.

The first part of the session will provide an overview on the target organs for diabetes drugs, mechanisms of action and affect on weight. In addition, new categories and types of glucose-lowering medications such as GLP-1 agonists, SGLT-2 inhibitors, and new formulations of insulin will be described. The second part of the session will focus on what the RDN needs to know regarding the expanding role of RDN in medication management. The impact of these medications on diabetes nutrition therapy plan also be discussed.

CPEU: 1.5
CPE Level: 2
Learning Codes: 5190, 3070, 5410

Speaker

  • Alison Evert, MS, RD, CDE (Program Planner)
  • Alison Evert, MS, RD, CDE
  • Patti Urbanski, MEd, RD, LD, CDE

Moderator

  • Marion Franz
  • SKU FNCE16307